5Lalwani N, Shanbhogue AK, Vikram R, et al. Current Up- date on Borderline Ovarian Neoplasms [ J ]. AIR Am J Ro- entgenol,2010,194(2 ) :330-336.
6Ren J, Peng Z, Yang K. A clinicopathologic multivariate a- nalysis affecting recurrence of borderline ovarian tumors [ J ]. Gynecol Onco1,2008,110 (2) : 162-167.
7Anfinan N,Sait K, Ghatage P, et al. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre[J]. Arch Gynecol Obstet,2011,284 (3) :731-735.
8Ferrero A, Strada I, Di Marcoberardino B, et al. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management[J]. Int J Gynecol Cancer,2012,22(7) : 1158-1162.
9Bell DA, Weinstock MA, Seully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis [ J ]. Cancer, 1988,62:2212-2222.
10Wu TI, Lee CL, Wu MY, et al. Prognostic factors predic- ting recurrence in borderline ovarian tumors[ J]. Gynecol Oncol,2009,114(2) :237-241.